BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34784305)

  • 21. Regional emphysema score is associated with tumor location and poor prognosis in completely resected NSCLC patients.
    Heo JW; Kang HS; Park CK; Kim SK; Kim JS; Kim JW; Kim SJ; Lee SH; Yeo CD
    BMC Pulm Med; 2020 Sep; 20(1):242. PubMed ID: 32917179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
    Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
    Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
    Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
    Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph Node Metastasis Location and Postoperative Adjuvant Chemotherapy in Patients With pN1 Stage IIB Non-small Cell Lung Cancer.
    Ito R; Tsukioka T; Izumi N; Komatsu H; Inoue H; Kimura T; Kishimoto K; Nishiyama N
    In Vivo; 2022; 36(1):355-360. PubMed ID: 34972734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between lower lobe location and upstaging for early-stage non-small cell lung cancer.
    Rocha AT; McCormack M; Montana G; Schreiber G
    Chest; 2004 Apr; 125(4):1424-30. PubMed ID: 15078755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
    Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
    World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Shigemoto Y; Suga K; Matsunaga N
    Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological characteristics and risk factors of station 4L lymph node metastasis of left non-small cell lung cancer].
    Shen L; Yun T; Guo J; Liu Y; Liang C
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1793-1798. PubMed ID: 33380404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study.
    Moulla Y; Gradistanac T; Wittekind C; Eichfeld U; Gockel I; Dietrich A
    J Cardiothorac Surg; 2019 Jan; 14(1):11. PubMed ID: 30651112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer.
    Zhao F; Zhen FX; Zhou Y; Huang CJ; Yu Y; Li J; Li QF; Zhu CX; Yang XY; You SH; Wu QG; Qin XY; Liu Y; Chen L; Wang W
    BMC Cancer; 2019 May; 19(1):444. PubMed ID: 31088404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advances in Lymph Node Metastasis and Lymph Node Dissection 
in Early Non-small Cell Lung Cancer].
    Lu Y; Ma T; Wang L; Xue T
    Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):520-525. PubMed ID: 31451143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe.
    Lin YH; Hung JJ; Yeh YC; Hsu WH
    Thorac Cancer; 2019 Feb; 10(2):312-320. PubMed ID: 30601596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The rule of lymph node metastasis of adenosquamous carcinoma of the lung].
    Li J; Zhang DC; He J; Liu XY; Mu JW; Zhang LZ
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):524-7. PubMed ID: 19950701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
    Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
    Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
    Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
    Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
    Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.